These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

763 related items for PubMed ID: 26893361

  • 1. Zinc finger protein ZBTB20 is an independent prognostic marker and promotes tumor growth of human hepatocellular carcinoma by repressing FoxO1.
    Kan H, Huang Y, Li X, Liu D, Chen J, Shu M.
    Oncotarget; 2016 Mar 22; 7(12):14336-49. PubMed ID: 26893361
    [Abstract] [Full Text] [Related]

  • 2. NK3 homeobox 1 (NKX3.1) up-regulates forkhead box O1 expression in hepatocellular carcinoma and thereby suppresses tumor proliferation and invasion.
    Jiang J, Liu Z, Ge C, Chen C, Zhao F, Li H, Chen T, Yao M, Li J.
    J Biol Chem; 2017 Nov 24; 292(47):19146-19159. PubMed ID: 28972178
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
    Du H, Xu Q, Xiao S, Wu Z, Gong J, Liu C, Ren G, Wu H.
    Life Sci; 2019 May 01; 224():1-11. PubMed ID: 30876939
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. MicroRNA-155 promotes tumor growth of human hepatocellular carcinoma by targeting ARID2.
    Zhang L, Wang W, Li X, He S, Yao J, Wang X, Zhang D, Sun X.
    Int J Oncol; 2016 Jun 01; 48(6):2425-34. PubMed ID: 27035278
    [Abstract] [Full Text] [Related]

  • 10. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
    Tu K, Dou C, Zheng X, Li C, Yang W, Yao Y, Liu Q.
    BMC Cancer; 2014 Dec 12; 14():938. PubMed ID: 25494879
    [Abstract] [Full Text] [Related]

  • 11. MicroRNA-301b-3p contributes to tumour growth of human hepatocellular carcinoma by repressing vestigial like family member 4.
    Guo Y, Yao B, Zhu Q, Xiao Z, Hu L, Liu X, Li L, Wang J, Xu Q, Yang L, Huang D.
    J Cell Mol Med; 2019 Aug 12; 23(8):5037-5047. PubMed ID: 31207037
    [Abstract] [Full Text] [Related]

  • 12. Bromodomain-containing protein 9 promotes hepatocellular carcinoma progression via activating the Wnt/β-catenin signaling pathway.
    Fang D, Wang MR, Guan JL, Han YY, Sheng JQ, Tian DA, Li PY.
    Exp Cell Res; 2021 Sep 15; 406(2):112727. PubMed ID: 34370992
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Transmembrane protein 106C promotes the development of hepatocellular carcinoma.
    Luo X, Han G, Lu R, Guan S, Wang Y, Ju L, Chen L, Shao J, Bian Z.
    J Cell Biochem; 2020 Nov 15; 121(11):4484-4495. PubMed ID: 32037603
    [Abstract] [Full Text] [Related]

  • 15. miR-192, a prognostic indicator, targets the SLC39A6/SNAIL pathway to reduce tumor metastasis in human hepatocellular carcinoma.
    Lian J, Jing Y, Dong Q, Huan L, Chen D, Bao C, Wang Q, Zhao F, Li J, Yao M, Qin L, Liang L, He X.
    Oncotarget; 2016 Jan 19; 7(3):2672-83. PubMed ID: 26684241
    [Abstract] [Full Text] [Related]

  • 16. Uridine-cytidine kinase 2 upregulation predicts poor prognosis of hepatocellular carcinoma and is associated with cancer aggressiveness.
    Huang S, Li J, Tam NL, Sun C, Hou Y, Hughes B, Wang Z, Zhou Q, He X, Wu L.
    Mol Carcinog; 2019 Apr 19; 58(4):603-615. PubMed ID: 30556610
    [Abstract] [Full Text] [Related]

  • 17. MicroRNA-1269 promotes proliferation in human hepatocellular carcinoma via downregulation of FOXO1.
    Yang XW, Shen GZ, Cao LQ, Jiang XF, Peng HP, Shen G, Chen D, Xue P.
    BMC Cancer; 2014 Dec 03; 14():909. PubMed ID: 25472505
    [Abstract] [Full Text] [Related]

  • 18. Aberrantly activated Gli2-KIF20A axis is crucial for growth of hepatocellular carcinoma and predicts poor prognosis.
    Shi C, Huang D, Lu N, Chen D, Zhang M, Yan Y, Deng L, Lu Q, Lu H, Luo S.
    Oncotarget; 2016 May 03; 7(18):26206-19. PubMed ID: 27036048
    [Abstract] [Full Text] [Related]

  • 19. Fbxw7 is an independent prognostic marker and induces apoptosis and growth arrest by regulating YAP abundance in hepatocellular carcinoma.
    Tu K, Yang W, Li C, Zheng X, Lu Z, Guo C, Yao Y, Liu Q.
    Mol Cancer; 2014 May 17; 13():110. PubMed ID: 24884509
    [Abstract] [Full Text] [Related]

  • 20. Downregulation of paraoxonase 3 contributes to aggressive human hepatocellular carcinoma progression and associates with poor prognosis.
    Jin Y, Li Q, Qiu J, Zhao X, Zheng C, Lv S, Bai Y, Shan Y, Ye LC.
    Tumour Biol; 2016 Oct 17; 37(10):14193-14203. PubMed ID: 27553024
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.